Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndrome
Eric D. Morrell, … , Mark M. Wurfel, Carmen Mikacenic
Eric D. Morrell, … , Mark M. Wurfel, Carmen Mikacenic
Published May 17, 2018
Citation Information: JCI Insight. 2018;3(10):e99281. https://doi.org/10.1172/jci.insight.99281.
View: Text | PDF
Research Article Immunology Pulmonology

Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndrome

  • Text
  • PDF
Abstract

Studies in human peripheral blood monocyte–derived macrophages in vitro have shown clear evidence that multiple macrophage polarization states exist. The extent to which different alveolar macrophage (AM) polarization states exist in homeostasis or in the setting of severe injury such as acute respiratory distress syndrome (ARDS) is largely unknown. We applied single-cell cytometry TOF (CyTOF) to simultaneously measure 36 cell-surface markers on CD45+ cells present in bronchoalveolar lavage from healthy volunteers, as well as mechanically ventilated subjects with and without ARDS. Visualization of the high-dimensional data with the t-distributed stochastic neighbor embedding algorithm demonstrated wide diversity of cell-surface marker profiles among CD33+CD71+CD163+ AMs. We then used a κ-nearest neighbor density estimation algorithm to statistically identify distinct alveolar myeloid subtypes, and we discerned 3 AM subtypes defined by CD169 and PD-L1 surface expression. The percentage of AMs that were classified into one of the 3 AM subtypes was significantly different between healthy and mechanically ventilated subjects. In an independent cohort of subjects with ARDS, PD-L1 gene expression and PD-L1/PD-1 pathway–associated gene sets were significantly decreased in AMs from patients who experienced prolonged mechanical ventilation or death. Unsupervised CyTOF analysis of alveolar leukocytes from human subjects has potential to identify expected and potentially novel myeloid populations that may be linked with clinical outcomes.

Authors

Eric D. Morrell, Alice Wiedeman, S. Alice Long, Sina A. Gharib, T. Eoin West, Shawn J. Skerrett, Mark M. Wurfel, Carmen Mikacenic

×

Figure 4

CD169 and PD-L1 distinguish alveolar macrophages (AMs) procured from different clinical populations.

Options: View larger image (or click on image) Download as PowerPoint
CD169 and PD-L1 distinguish alveolar macrophages (AMs) procured from dif...
(A) The hierarchical gating strategy used to identify AMs is based on the Divisive Marker Tree (DMT) shown in Figure 2. (B) Contour plot demonstrating the manually drawn gates for CD169 and PD-L1 AM subtypes within all CD45RAloCD15loCD33hi events from all 16 alveolar samples in the HMC-BAL cohort. (C) The population frequency of each CD169/PD-L1 AM subtype was different between nonmechanically ventilated healthy subjects and mechanically ventilated critically ill subjects (n = 4 not mechanically ventilated, n = 12 mechanically ventilated). (D) The population frequency of each CD169/PD-L1 AM subtype suggested a difference between non-ARDS and ARDS subjects (n = 6 non-ARDS, n = 6 ARDS). Shown are the individual values and median ± interquartile range (IQR) population frequencies of each AM subtype among total CD45RAloCD15loCD33hi AMs. Each comparison was made with a Mann-Whitney U test. **P ≤ 0.01.

Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts